摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[1,2,4]三唑-1-基乙酸 | 22095-34-7

中文名称
[1,2,4]三唑-1-基乙酸
中文别名
2-(1-氨乙基)呋喃;1-呋喃-2-乙胺;1-(2-呋喃)-1-乙胺
英文名称
1-(furan-2-yl)ethanamine
英文别名
1-(furan-2-yl)ethan-1-amine
[1,2,4]三唑-1-基乙酸化学式
CAS
22095-34-7
化学式
C6H9NO
mdl
MFCD05215252
分子量
111.144
InChiKey
JYXGCMLOKDKUAX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    148 °C
  • 密度:
    0.998

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    8
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    39.2
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 海关编码:
    2932190090

SDS

SDS:98c2ff16a4ddb8e8301274742020eb17
查看
Name: 1-(2-Furyl)-1-ethanamine Material Safety Data Sheet
Synonym:
CAS: 22095-34-7
Section 1 - Chemical Product MSDS Name:1-(2-Furyl)-1-ethanamine Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
22095-34-7 1-(2-Furyl)-1-ethanamine 90+% 244-778-1
Hazard Symbols: C
Risk Phrases: 10 35

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Flammable. Causes severe burns.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Flammable liquid and vapor. Combustible liquid.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Remove all sources of ignition.

Section 7 - HANDLING and STORAGE
Handling:
Use spark-proof tools and explosion proof equipment. Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Keep under a nitrogen blanket. Corrosives area.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low. Use adequate general or local explosion-proof ventilation to keep airborne levels to acceptable levels.
Exposure Limits CAS# 22095-34-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 148 - 149 deg C @760mm Hg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 0.998
Molecular Formula: C6H9NO
Molecular Weight: 111.14

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures. Moisture sensitive.
Conditions to Avoid:
Incompatible materials, ignition sources.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids, acid chlorides.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 22095-34-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(2-Furyl)-1-ethanamine - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 10 Flammable.
R 35 Causes severe burns.
Safety Phrases:
S 16 Keep away from sources of ignition - No
smoking.
S 23 Do not inhale gas/fumes/vapour/spray.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 22095-34-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 22095-34-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 22095-34-7 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Candida antarctica B lipase catalysed resolution of (±)-1-(heteroaryl)ethylamines
    摘要:
    Candida antarctica B lipase is an efficient catalyst for the enantioselective acetylation of (+/-)-1-(heteroaryl)ethylamines (+/-)-1a-c. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0957-4166(97)00330-3
  • 作为产物:
    描述:
    2-乙酰基呋喃 在 ammonium acetate 、 sodium cyanoborohydride 作用下, 以 甲醇 为溶剂, 反应 24.0h, 生成 [1,2,4]三唑-1-基乙酸
    参考文献:
    名称:
    工程胺脱氢酶对烷基(杂)芳基酮的直接不对称还原胺化
    摘要:
    已经通过定向进化方法开发了一种新型胺脱氢酶 ( J a-AmDH),用于烷基(杂)芳基酮的直接不对称还原胺化。该工程酶以高产率和优异的对映选择性提供了一系列手性α-(杂)芳基伯胺。
    DOI:
    10.1002/anie.202202264
点击查看最新优质反应信息

文献信息

  • Reductive Amination of Ketonic Compounds Catalyzed by Cp*Ir(III) Complexes Bearing a Picolinamidato Ligand
    作者:Kouichi Tanaka、Takashi Miki、Kunihiko Murata、Ayumi Yamaguchi、Yoshihito Kayaki、Shigeki Kuwata、Takao Ikariya、Masahito Watanabe
    DOI:10.1021/acs.joc.9b01565
    日期:2019.9.6
    Cp*Ir complexes bearing a 2-picolinamide moiety serve as effective catalysts for the direct reductive amination of ketonic compounds to give primary amines under transfer hydrogenation conditions using ammonium formate as both the nitrogen and hydrogen source. The clean and operationally simple transformation proceeds with a substrate to catalyst molar ratio (S/C) of up to 20,000 at relatively low
    带有2-吡啶甲酸酰胺部分的Cp * Ir配合物可作为有效的催化剂,用于在酮的转移氢化条件下,使用甲酸铵作为氮源和氢源,对酮类化合物进行直接还原胺化,从而生成伯胺。清洁且操作简单的转化过程是在相对较低的温度下以高达20,000的底物与催化剂的摩尔比(S / C)进行的,并且对伯胺表现出出色的化学选择性。
  • Design, Synthesis, and Biological Evaluation of New Inhibitors of the Endocannabinoid Uptake:  Comparison with Effects on Fatty Acid Amidohydrolase
    作者:María L. López-Rodríguez、Alma Viso、Silvia Ortega-Gutiérrez、Christopher J. Fowler、Gunnar Tiger、Eva de Lago、Javier Fernández-Ruiz、José A. Ramos
    DOI:10.1021/jm0210818
    日期:2003.4.1
    A new series of arachidonic acid derivatives were synthesized and evaluated as inhibitors of the endocannabinoid uptake. Most of them are able to inhibit anandamide uptake with IC(50) values in the low micromolar range (IC(50) = 0.8-24 microM). In general, the compounds had only weak effects upon CB(1), CB(2), and VR(1) receptors (K(i) > 1000-10000 nM). In addition, there was no obvious relationship
    合成了一系列新的花生四烯酸衍生物,并将其评估为内源性大麻素吸收的抑制剂。它们中的大多数能够以较低的微摩尔范围(IC(50)= 0.8-24 microM)的IC(50)值抑制anandamide的吸收。通常,这些化合物对CB(1),CB(2)和VR(1)受体的作用很小(K(i)> 1000-10000 nM)。此外,化合物通过脂肪酸酰胺水解酶(FAAH; IC(50)= 30-113 microM)影响anandamide摄取和抑制anandamide代谢的能力之间没有明显的关系。这表明该化合物对FAAH抑制没有发挥第二作用。希望这些化合物,尤其是本系列中最有效的化合物(化合物5,UCM707,其对Anandamide的吸收和FAAH的IC(50)值分别为0.8和30 microM),
  • [EN] HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES UTILES EN TANT QUE MODULATEURS DU TNF ALPHA
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2017023905A1
    公开(公告)日:2017-02-09
    Disclosed are compounds of Formula (I) or a salt thereof, wherein: A is CR1 or N; B is CR3 or N; D is CR4 or N; L1 is -(CR7R7)m-; L2 is -(CR7R7)n-; and X, Z, R1, R2, R3, R4, R5,and R6 are define herein. Also disclosed are methods of using such compounds as modulators of TNFα, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
    披露了公式(I)化合物或其盐,其中:A是CR1或N;B是CR3或N;D是CR4或N;L1是-(CR7R7)m-;L2是-(CR7R7)n-;X,Z,R1,R2,R3,R4,R5和R6都在此定义。还披露了将此类化合物用作调节TNFα的调节剂的方法,以及包含此类化合物的药物组合物。这些化合物可用于治疗炎症和自身免疫性疾病。
  • [EN] MALONAMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS<br/>[FR] DERIVES DE MALONAMIDE UTILISES COMME INHIBITEURS DE LA GAMMA-SECRETASE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2004069826A1
    公开(公告)日:2004-08-19
    The invention relates to malonamide derivatives of formula (IA) or (IB) and to pharmaceutically suitable acid addition salts thereof. The compounds are Ϝ-secretase inhibitors and the related compounds may be useful in the treatment of Alzheimer's disease.
    这项发明涉及公式(IA)或(IB)的马隆酰胺衍生物及其药用适宜的酸盐。这些化合物是Ϝ-分泌酶抑制剂,相关化合物可能在治疗阿尔茨海默病方面有用。
  • Scope and limitations of reductive amination catalyzed by half-sandwich iridium complexes under mild reaction conditions
    作者:Dat P. Nguyen、Rudolph N. Sladek、Loi H. Do
    DOI:10.1016/j.tetlet.2020.152196
    日期:2020.8
    broad assortment of carbonyl-containing compounds. In aqueous media, selective reduction of carbonyls to 1° amines was achieved in the absence of acids. Unfortunately, at Ir catalyst concentrations of <1 mM in water, reductive amination efficiency dropped significantly, which suggest that this catalytic methodology might be not suitable for aqueous applications where very low catalyst concentration is
    使用甲酸铵作为氮源和氢化物源的半夹心铱配合物可以促进醛和酮向 1°胺的转化。为了优化这种绿色化学合成方法,我们在生理温度 (37 °C) 和环境压力下在常见极性溶剂中测试了各种羰基底物。我们发现,在甲醇中,对于广泛种类的含羰基化合物,可以实现胺对醇/酰胺产物的优异选择性。在水性介质中,在不存在酸的情况下,羰基化合物选择性还原为 1° 胺。不幸的是,在水中 Ir 催化剂浓度 <1 mM 时,还原胺化效率显着下降,
查看更多

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰